Radiology, Vol 189, 417-422, Copyright © 1993 by Radiological Society of North America

ARTICLES

Colorectal metastases to the liver: selective chemoembolization

EK Lang and CL Brown Jr
Department of Radiology, Louisiana State University, New Orleans 70112.

PURPOSE: To evaluate the efficacy and safety of selective chemoembolization in patients with colorectal metastases to the liver. MATERIALS AND METHODS: Forty-six patients underwent the regimen, which involved use of doxorubicin and ethiodized oil, with 75% selectively administered to different subsegments and 25% into the respective main hepatic artery. RESULTS: In eight patients, the lesions disappeared and carcinoembryonic antigen levels returned to normal. Eleven patients showed no disease progression for 12 months; two others, for 24 months. Thirteen patients died; three were lost to follow-up in the 1st year. Six patients were followed up for 5 years, seven for 3 years, 16 for 2 years, and 30 for 1 year. Five of seven patients who survived 3 years or more exhibited homogeneous distribution of the chemoembolic agent throughout the metastatic tumor. CONCLUSION: Selective chemoembolization is recommended for treatment of patients with colorectal metastases to the liver, a resectable primary tumor, and no evidence of other metastatic disease.

This article has been cited by other articles:

				E. Liapi and J.-F. H. Geschwind Transcatheter and Ablative Therapeutic Approaches for Solid Malignancies J. Clin. Oncol., March 10, 2007; 25(8): 978 - 986. [Abstract] [Full Text] [PDF]

				K. Stuart Chemoembolization in the Management of Liver Tumors Oncologist, October 1, 2003; 8(5): 425 - 437. [Abstract] [Full Text] [PDF]

				R. G. Abramson, M. P. Rosen, L. J. Perry, D. P. Brophy, S. L. Raeburn, and K. E. Stuart Cost-effectiveness of Hepatic Arterial Chemoembolization for Colorectal Liver Metastases Refractory to Systemic Chemotherapy Radiology, August 1, 2000; 216(2): 485 - 491. [Abstract] [Full Text]

				J. Gates, G. G. Hartnell, K. E. Stuart, and M. E. Clouse Chemoembolization of Hepatic Neoplasms: Safety, Complications, and When to Worry RadioGraphics, March 1, 1999; 19(2): 399 - 414. [Abstract] [Full Text] [PDF]

				L. M. Bavisotto, N. H. Patel, S. J. Althaus, D. M. Coldwell, H. V. Nghiem, T. Thompson, B. Storer, and C. R. Thomas Jr. Hepatic Transcatheter Arterial Chemoembolization Alternating with Systemic Protracted Continuous Infusion 5-Fluorouracil for Gastrointestinal Malignancies Metastatic to Liver: A Phase II Trial of the Puget Sound Oncology Consortium (PSOC 1104) Clin. Cancer Res., January 1, 1999; 5(1): 95 - 109. [Abstract] [Full Text] [PDF]

				J.-S. Yu, K. W. Kim, M.-S. Park, and S.-W. Yoon Bile Duct Injuries Leading to Portal Vein Obliteration after Transcatheter Arterial Chemoembolization in the Liver: CT Findings and Initial Observations Radiology, November 1, 2001; 221(2): 429 - 436. [Abstract] [Full Text] [PDF]